Fenaperone

This classification denotes an anxiolytic with the molecular formula C21H29FN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V6W7F1R86P, chemically known as 4-(3-(p-fluorobenzoyl)-propyl)-1-piperazinecarboxylic acid, cyclohexyl ester. but generally known as fenaperone, which bears US NIH Compound Identifier 198061. European Medicines Agency schedules Fenaperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07540MIG. The term FENAPERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). FENAPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fenaperone under HS 29335995 and SITC 51576. As of Q4 2014, FENAPERONE remains the US FDA Preferred Term for this commodity. Fenaperone bears US NLM identifiers UMLS ID C1880749 and NCI Concept Code C65638. SMILES: FC1CCC(C(=O)CCCN2CCN(CC2)C(=O)OC2CCCCC2)CC1.